0001104659-18-045045.txt : 20180713
0001104659-18-045045.hdr.sgml : 20180713
20180713154006
ACCESSION NUMBER: 0001104659-18-045045
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180630
FILED AS OF DATE: 20180713
DATE AS OF CHANGE: 20180713
EFFECTIVENESS DATE: 20180713
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 18952477
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
06-30-2018
06-30-2018
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Managing Director, Versant Venture Management, LLC
415-801-8100
Robin L. Praeger
San Francisco
CA
07-11-2018
0
9
320525517
false
INFORMATION TABLE
2
a18-17189_1informationtable.xml
INFORMATION TABLE
Clovis Oncology, Inc.
Common Stock
189464100
4631347
101855
SH
OTR
0
101855
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
14072225
1048601
SH
OTR
0
1048601
0
Achaogen, Inc.
Common Stock
004449104
11094776
1281152
SH
OTR
0
1281152
0
Second Sight Medical Products, Inc.
Common Stock
81362J100
7458339
4492975
SH
OTR
0
4492975
0
Ocular Therapeutix, Inc.
Common Stock
67576A100
14953842
2215384
SH
OTR
0
2215384
0
Audentes Therapeutics, Inc.
Common Stock
05070R104
46028339
1204615
SH
OTR
0
1204615
0
ImmuneDesign Corp.
Common Stock
45252L103
10047356
2208210
SH
OTR
0
2208210
0
CRISPR Therapeutics AG
Common Stock
H17182108
212057436
3608874
SH
OTR
0
3608874
0
OpGen, Inc.
Common Stock
68373L109
181857
102167
SH
OTR
0
102167
0